Technical information
Manufacturer
Laboratoires PROSTRAKAN PHARMA
Presentation
DROLEPTAN 2,5 mg/ 1ml, solution injectable (IV) B/10 - CIP 561 122-8
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
9kcLaSsThB2yXDab